Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction

Authors: Mahmoud Abdellatif, Francisco Vasques-Nóvoa, Viktoria Trummer-Herbst, Sylvère Durand, Franziska Koser, Moydul Islam, Jihoon Nah, Eun-Ah Sung, Ruli Feng, Fanny Aprahamian, Andreas Prokesch, Pablo Zardoya-Laguardia, Junichi Sadoshima, Abhinav Diwan, Wolfgang A Linke, João Pedro Ferreira, Guido Kroemer, Simon Sedej

Published: 2025-02-25

DOI: 10.1093/eurheartj/ehaf062

Source: Full article


Abstract

No abstract found.